Bunyamin ARI, Erhan AKDEMİR, Ahmed Arif UZUN, Arda BİLİR
The Medical Bulletin of Haseki - 2026;64(4):264-270
Aim: Aseptic loosening remains one of the leading causes of late failure after hip and knee arthroplasty, and its diagnosis is often challenging because imaging and conventional inflammatory markers have limited specificity. We aimed to evaluate and compare the diagnostic performance of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) in detecting aseptic loosening following hip and knee arthroplasty. Methods: This single-center, retrospective diagnostic accuracy study included 291 patients who underwent three-phase bone scintigraphy for suspected prosthetic loosening between 2020 and 2025. Patients were classified into aseptic loosening and control groups based on scintigraphic findings supported by clinical evaluation. Hematological parameters were obtained from complete blood counts, and NLR, PLR, and MLR were calculated. Diagnostic performance was assessed using receiver operating characteristic curve analysis, and optimal cut-off values were determined using the Youden index. Results: In knee arthroplasty, MLR was significantly higher and the white blood cell count was significantly lower in patients with aseptic loosening, whereas NLR and PLR showed no significant differences. In hip arthroplasty, both PLR and MLR were significantly elevated in the loosening group. Receiver operating characteristic analysis demonstrated the low-to-moderate discriminatory ability of MLR in both knee (AUC=0.61) and hip (AUC=0.64) arthroplasty, whereas PLR achieved the highest diagnostic performance in the hip group (AUC=0.68) with high sensitivity. Neutrophil-to-lymphocyte ratio consistently demonstrated limited diagnostic value across both joint types. Conclusion: Monocyte-to-lymphocyte ratio and PLR demonstrate modest diagnostic utility in the evaluation of aseptic loosening after hip and knee arthroplasty, with joint-specific differences in performance. These hematological markers should be considered adjunctive tools rather than standalone diagnostic tests and may contribute to clinical decision-making when interpreted alongside imaging findings and clinical assessment.